Stockreport

Here's Why NewAmsterdam Pharma Company N.V. (NAMS) Surged 23% in Q4 [Yahoo! Finance]

NewAmsterdam Pharma Company N.V. - Ordinary Shares  (NAMS) 
PDF A copy of the letter can be downloaded here . The strategy returned 3.70% (gross) and 3.45% (net) in the fourth quarter compared to a 1.22% return for the Russell 2000 G [Read more]